Dynamics of IDH1 Mutation and Protein Expression Between Primary and Recurrent Gliomas and Their Prognostic Significance. [PDF]
Yu W, Guo S, Liu B, Wei Q.
europepmc +1 more source
Age-specific survival after breast conservation versus mastectomy for ductal carcinoma in situ of the breast. [PDF]
de Boniface J +3 more
europepmc +1 more source
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato +27 more
wiley +1 more source
Objective Orofacial manifestations are significantly impactful in patients with systemic sclerosis (SSc) yet remain understudied, with no dedicated clinical guidelines to inform their management. Methods An international online survey comprised38 questions addressing orofacial manifestations of SSc, including patients’ confidence in their treating ...
Eleni Deligianni +4 more
wiley +1 more source
Pathological Tumor-Nodal Response Patterns After Neoadjuvant Treatment for Rectal Cancer: Prognostic Impact of Residual ypN-Positive Disease. [PDF]
Aytin YE, Gorca SB.
europepmc +1 more source
Recurrent Cellulitis in Lymphedema: Integrating Antibiotic Prophylaxis, Conservative Therapy, Local Disease Control, and Lymphaticovenular Anastomosis. [PDF]
Mihara M, Hara H.
europepmc +1 more source
Cementoblastoma With Bony and Soft Tissue Recurrences Following a Primary Molar Lesion: A Case Report. [PDF]
Allam E, Thiede CC, Lin YL.
europepmc +1 more source
Transverse colon cancer as an independent predictor of locoregional recurrence in patients with stage III colon cancer: a retrospective cohort study. [PDF]
Jo MH +8 more
europepmc +1 more source
D-Dimer as a Novel Factor for Recurrent Chronic Subdural Hematoma: Development and Assessment of a New Predictive Nomogram. [PDF]
Wei J, Li Z, Wang W, Cai Q.
europepmc +1 more source

